Study | LOE (1a to 5) | Study design | Study groups | Clinical endpoints efficacy | Conclusion |
---|---|---|---|---|---|
Ikeda et al. [99] | 3 | Prospective RCT | Adult CRSwNP and CRSsNP patients undergoing ESS | 1. Sinonasal and pulmonary symptoms 2. Systemic GCS need | 1. Improvement of FEV1 2. No significant changes in systemic GCS need |